Drug Discovery in Prevention and Treatment of COVID-19

Overview

In early 2020, the outbreak of COVID-19 rapidly escalated into a global pandemic, claiming over 100,000 lives as reported by the WHO, a figure significantly higher than seasonal flu. Recognizing the critical need for comprehensive knowledge to aid in self-protection and future drug development, the School of Pharmaceutical Sciences at Tsinghua University, in collaboration with the Global Health Drug Discovery Institute (GHDDI), has launched an educational initiative specifically focused on drug discovery for the prevention and treatment of COVID-19.

This curriculum delves into the essential aspects of COVID-19, including clinical diagnosis, prevention, and therapeutic strategies.

It examines various drug development approaches targeting the virus, explores the specific virus-host interactions involved in COVID-19, and highlights the role of artificial intelligence (AI) in accelerating drug discovery processes. Tsinghua University is providing this course for free, making it accessible to researchers, clinicians, and policymakers globally, aiming to equip them with the knowledge needed to effectively combat the ongoing pandemic.

Join us in this endeavor as we share valuable insights to help responders around the world.

This course is available under the categories of Artificial Intelligence Courses and COVID-19 Courses, offered through XuetangX.

Subjects